Aktien Sensor

Grifols SA is expected to deliver strong quarterly earnings on July 29, 2025, with analysts predicting a 3%+ revenue growth and significant increases in earnings per share.

Recordati Industria Chimica E Farmaceutica Spa has demonstrated a steady financial performance, with a stable stock price and valuation ratios, indicating its ability to navigate turbulent markets.

Mettler-Toledo International Inc.’s stock price has declined by 10.65% over the past year, but its market value remains significant at over $26 billion.

Galderma Group AG’s stock price has declined due to market volatility, but the company’s long-term prospects remain strong due to its commitment to innovative dermatological solutions.

Roche Holding AG’s gene therapy, Elevidys, has been rejected by the European Medicines Agency, dealing a setback to the company’s efforts to treat Duchenne muscular dystrophy.

Thermo Fisher Scientific Inc. has received a mixed outlook from analysts, with some firms lowering stock price targets due to growth concerns, while others remain optimistic about the company’s prospects in the pharmaceutical research and developmen…

Bristol-Myers Squibb has appointed Cristian Massacesi as its new Chief Medical Officer and Head of Development, bringing over 20 years of industry experience to the role.

Merck & Co Inc is a promising investment opportunity due to its focus on cancer research and development of targeted treatments, driven by a growing demand for effective cancer therapies.

Genmab A/S’s stock price has broken through a key moving average, signaling a strong buying opportunity as the biotech company prepares to expand its global presence and capitalize on emerging opportunities.

Avantor has appointed Emmanuel Ligner as its new President and CEO, marking a significant milestone for the company as it looks to drive growth and capitalize on new opportunities.